Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Symbol: 
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
06/02/20248:00AMBusiness WireENHERTU® (fam-trastuzumab deruxtecan-nxki) demonstrated a median progression-free survival of 13.2 months in HR-positive, HER2-low and HER2-ultralow metastatic breast cancer following one or more lines of endocrine therapyNASDAQ:AZNAstraZeneca PLC
06/02/20248:00AMGlobeNewswire Inc.CryptoHeap Launches Comprehensive Strategy for Crypto Staking Amidst Market Fluctuations
06/02/20248:00AMBusiness WireGilead and Arcus Announce Etrumadenant Plus Zimberelimab Regimen Significantly Reduced the Risk of Death in Third-line Metastatic Colorectal CancerNASDAQ:GILDGilead Sciences Inc
06/02/20248:00AMGlobeNewswire Inc.Intellia Therapeutics Announces Positive Long-Term Data from Ongoing Phase 1 Study of NTLA-2002, an Investigational In Vivo CRISPR Gene Editing Treatment for Hereditary Angioedema (HAE)NASDAQ:NTLAIntellia Therapeutics Inc
06/02/20248:00AMBusiness WireGilead and Arcus Announce Etrumadenant Plus Zimberelimab Regimen Significantly Reduced the Risk of Death in Third-line Metastatic Colorectal CancerNYSE:RCUSArcus Biosciences Inc
06/02/20248:00AMBusiness WireGilead and Arcus Announce Etrumadenant Plus Zimberelimab Regimen Significantly Reduced the Risk of Death in Third-line Metastatic Colorectal CancerNASDAQ:GILDGilead Sciences Inc
06/02/20248:00AMGlobeNewswire Inc.William Miller Spearheads Launch of Pioneering OkayCoin Staking Protocol
06/02/20248:00AMBusiness WireMassive Bio and Mika Health Combine AI and Next-Generation Sequencing Biomarker Testing to Empower Cancer Patients On Treatment and Those Searching for and Participating in Clinical Trials in the United States and Europe
06/02/20248:00AMBusiness WireENHERTU® Demonstrated a Median Progression-Free Survival of 13.2 Months in HR Positive, HER2 Low and HER2 Ultralow Metastatic Breast Cancer Following One or More Lines of Endocrine Therapy
06/02/20248:00AMBusiness WireGilead and Arcus Announce Etrumadenant Plus Zimberelimab Regimen Significantly Reduced the Risk of Death in Third-line Metastatic Colorectal CancerNYSE:RCUSArcus Biosciences Inc
06/02/20248:00AMPR Newswire (US)OncoHost Announces New Study on Biomarkers for Renal Cell Carcinoma
06/02/20247:20AMPR Newswire (Canada)/R A P P E L -- Avis aux médias - Itinéraire de la vice-première ministre pour le dimanche 2 juin 2024/
06/02/20247:20AMPR Newswire (Canada)/R E M I N D E R -- Media Advisory - Deputy Prime Minister's itinerary for Sunday, June 2, 2024/
06/02/20247:00AMBusiness WireJune Joy at Juicy Stakes Casino
06/02/20247:00AMPR Newswire (Canada)/R E M I N D E R -- Media Advisory - Prime Minister's itinerary for Sunday, June 2, 2024/
06/02/20247:00AMPR Newswire (US)Fast Guard Service Releases Guide to Choosing the Best Fire Watch Service
06/02/20247:00AMPR Newswire (Canada)/R A P P E L -- Avis aux médias - Itinéraire du premier ministre pour le dimanche 2 juin 2024/
06/02/20246:41AMAlliance NewsAlliance NewsIsrael fights Hamas as mediators urge both to accept Gaza truce plan
06/02/20246:35AMAlliance NewsAlliance NewsOPEC+ anxious to maintain unity as some members head to Riyadh
06/02/20246:32AMAlliance NewsAlliance NewsDong Jun says Beijing ready to "forcefully" stop Taiwan independence
06/02/20246:29AMAlliance NewsAlliance NewsNvidia head, top chip CEOs to lay out AI plans at Taiwan expoTG:NVDNVIDIA Corp
06/02/20246:20AMAlliance NewsAlliance NewsPRESS: Sanofi proceeds with EUR20 billion consumer healthcare spin-off
06/02/20246:18AMPR Newswire (US)Sunvozertinib's Global Pivotal WU-KONG1B Study Meets Primary Endpoint in Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
06/02/20246:00AMPR Newswire (Canada)/R E P R I S E -- Avis aux médias - En pleine négociation, les intervenantes en petite enfance de la FIPEQ-CSQ participeront à l'activité de mobilisation de Ma place au travail/
06/02/20246:00AMPR Newswire (Canada)/R E P E A T -- Media Advisory: Infrastructure Announcement in Halifax/
06/02/20246:00AMPR Newswire (Canada)/R E P R I S E -- Avis aux médias : Annonce en matière d'infrastructure à Halifax/
06/02/20245:00AMPR Newswire (Canada)AVIS DE FERMETURE DE RUES : aujourd'hui, dimanche 2 juin, à l'occasion du Tour de l'Île de Montréal
06/02/20244:00AMGlobeNewswire Inc.BioCryst Presents New Real-world Evidence Showing Reductions in Attack Rates in HAE Patients with Normal C1-Inhibitor after Beginning ORLADEYO® (berotralstat) TreatmentNASDAQ:BCRXBioCryst Pharmaceuticals Inc
06/02/20242:08AMPR Newswire (Canada)Ontario Lottery and Gaming Corporation - EVENING LOTTERY WINNING NUMBERS - June 1, 2024
06/02/20242:00AMGlobeNewswire Inc.ePac Flexible Packaging Sets Strategy for Continued Double-Digit Growth

Your Recent History

Delayed Upgrade Clock